Palantir's Controversial Contracts: A Tale of Data, Deportations, and Healthcare
A tech giant is raking in millions from public hospitals, but at what cost? New York City's public hospital system is quietly funneling millions of dollars to Palantir, a company with a dark history of aiding controversial government operations. This revelation raises critical questions about the ethics of data-driven healthcare and the blurred lines between public services and private interests.
The Intercept's investigation uncovers a $4 million deal between the New York City Health and Hospitals Corporation and Palantir, a data analysis firm with deep ties to the Pentagon and U.S. intelligence. The goal? To enhance the tracking and billing of services provided at public hospitals and clinics, particularly for Medicaid and other public benefits. But here's where it gets controversial: Palantir's software automates the scanning of patient health notes to increase charges, potentially impacting the most vulnerable patients.
Palantir's involvement in healthcare is a stark contrast to its notorious past. The company has been a key player in facilitating warfare, mass deportations, and widespread surveillance. It was exposed as a behind-the-scenes enabler of XKEYSCORE, the NSA's bulk surveillance program, and has faced global criticism for its partnership with the Israeli military during the Gaza conflict. But it's Palantir's collaboration with U.S. Immigration and Customs Enforcement (ICE) that has sparked the most outrage.
The company's deportation tools are now being used to target immigrants in New York. Palantir provides case management software to ICE, which, according to federal documents, is critical to the agency's operations. Activists and community organizers are alarmed by this connection. Kenny Morris, from the American Friend Service Committee, condemns the situation, stating that Palantir's involvement endangers immigrants and undermines trust in public healthcare.
New York City Health and Hospitals, the nation's largest municipal healthcare system, serves over 1 million New Yorkers annually. The contract with Palantir allows the company to access and use patients' protected health information (PHI) with the system's permission. While de-identification processes are in place, critics argue that re-identifying personal data is often straightforward, especially in the hands of a data-mining expert like Palantir.
Civil liberties advocates warn that sharing sensitive data with Palantir puts immigrants at risk. Beth Haroules, from the New York Civil Liberties Union, emphasizes the right to privacy and the potential consequences of data sharing. Similar concerns have arisen in the U.K., where Palantir's partnership with the National Health Service has faced growing opposition.
Local activists argue that Palantir's involvement directly conflicts with the hospital system's mission. Jonathan Westin, from Climate Organizing Hub, believes Palantir's data-driven approach targets the very patients NYCHH aims to serve. Hannah Drummond, a nurse and organizer, highlights the broader impact of Palantir's technology, from immigrant deportations to potential patient privacy breaches. The company's right-wing CEO, Alex Karp, has been a vocal critic of New York City's democratic socialist mayor, Zohran Mamdani, adding a political twist to the controversy.
As the debate rages on, one question remains: Should a company with Palantir's controversial track record be trusted with the sensitive data of New York's public healthcare system? The silence from city officials and Palantir's spokesperson leaves the public with more questions than answers. And this is the part most people miss: How can we ensure ethical data practices in healthcare without compromising patient privacy and public trust?
